ロード中...
Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models
Duchenne muscular dystrophy (DMD) is a devastating disease caused by mutations in dystrophin that compromise sarcolemma integrity. Currently, there is no treatment for DMD. Mutations in transient receptor potential mucolipin 1 (ML1), a lysosomal Ca(2+) channel required for lysosomal exocytosis, prod...
保存先:
| 出版年: | Sci Adv |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Association for the Advancement of Science
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032923/ https://ncbi.nlm.nih.gov/pubmed/32128386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aaz2736 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|